vs

Side-by-side financial comparison of Outset Medical, Inc. (OM) and Valens Semiconductor Ltd. (VLN). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $17.3M, roughly 1.7× Valens Semiconductor Ltd.). Valens Semiconductor Ltd. runs the higher net margin — -42.2% vs -67.5%, a 25.3% gap on every dollar of revenue. On growth, Valens Semiconductor Ltd. posted the faster year-over-year revenue change (8.1% vs -2.0%). Valens Semiconductor Ltd. produced more free cash flow last quarter ($-4.9M vs $-9.7M).

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

Valens Semiconductor (Valens) is an Israeli fabless manufacturing company providing semiconductors for the automotive and audio-video industries. Valens provides semiconductor products for the distribution of uncompressed ultra-high-definition (UHD) multimedia content and in-vehicle connectivity applications. The company is a member of the MIPI Alliance and developed the first-to-market chipset that is compliant with the MIPI A-PHY standard. Valens invented the technology behind the HDBaseT s...

OM vs VLN — Head-to-Head

Bigger by revenue
OM
OM
1.7× larger
OM
$28.9M
$17.3M
VLN
Growing faster (revenue YoY)
VLN
VLN
+10.1% gap
VLN
8.1%
-2.0%
OM
Higher net margin
VLN
VLN
25.3% more per $
VLN
-42.2%
-67.5%
OM
More free cash flow
VLN
VLN
$4.8M more FCF
VLN
$-4.9M
$-9.7M
OM

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
OM
OM
VLN
VLN
Revenue
$28.9M
$17.3M
Net Profit
$-19.5M
$-7.3M
Gross Margin
42.4%
63.0%
Operating Margin
-61.1%
-46.4%
Net Margin
-67.5%
-42.2%
Revenue YoY
-2.0%
8.1%
Net Profit YoY
24.0%
29.3%
EPS (diluted)
$0.33
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OM
OM
VLN
VLN
Q4 25
$28.9M
Q3 25
$29.4M
$17.3M
Q2 25
$31.4M
$17.1M
Q1 25
$29.8M
$16.8M
Q4 24
$29.5M
Q3 24
$28.7M
$16.0M
Q2 24
$27.4M
$13.6M
Q1 24
$28.2M
Net Profit
OM
OM
VLN
VLN
Q4 25
$-19.5M
Q3 25
$-17.8M
$-7.3M
Q2 25
$-18.5M
$-7.2M
Q1 25
$-25.8M
$-8.3M
Q4 24
$-25.6M
Q3 24
$-27.9M
$-10.4M
Q2 24
$-34.5M
$-8.9M
Q1 24
$-39.9M
Gross Margin
OM
OM
VLN
VLN
Q4 25
42.4%
Q3 25
39.4%
63.0%
Q2 25
37.8%
63.5%
Q1 25
37.2%
62.9%
Q4 24
36.5%
Q3 24
34.3%
56.4%
Q2 24
35.7%
61.4%
Q1 24
29.2%
Operating Margin
OM
OM
VLN
VLN
Q4 25
-61.1%
Q3 25
-53.7%
-46.4%
Q2 25
-53.7%
-43.3%
Q1 25
-55.1%
-56.2%
Q4 24
-74.2%
Q3 24
-83.2%
-76.3%
Q2 24
-112.3%
-69.2%
Q1 24
-131.0%
Net Margin
OM
OM
VLN
VLN
Q4 25
-67.5%
Q3 25
-60.6%
-42.2%
Q2 25
-59.0%
-42.1%
Q1 25
-86.7%
-49.4%
Q4 24
-87.0%
Q3 24
-97.5%
-64.6%
Q2 24
-125.8%
-65.2%
Q1 24
-141.8%
EPS (diluted)
OM
OM
VLN
VLN
Q4 25
$0.33
Q3 25
$-1.00
$-0.07
Q2 25
$-1.04
$-0.07
Q1 25
$-3.66
$-0.08
Q4 24
$-7.21
Q3 24
$-8.02
$-0.10
Q2 24
$-9.96
$-0.08
Q1 24
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OM
OM
VLN
VLN
Cash + ST InvestmentsLiquidity on hand
$168.9M
$93.5M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$127.0M
$108.8M
Total Assets
$264.5M
$136.7M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OM
OM
VLN
VLN
Q4 25
$168.9M
Q3 25
$178.6M
$93.5M
Q2 25
$184.1M
$102.7M
Q1 25
$189.0M
$112.5M
Q4 24
$158.7M
Q3 24
$175.6M
$133.1M
Q2 24
$194.8M
$105.9M
Q1 24
$226.9M
Total Debt
OM
OM
VLN
VLN
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
OM
OM
VLN
VLN
Q4 25
$127.0M
Q3 25
$142.4M
$108.8M
Q2 25
$154.8M
$116.5M
Q1 25
$169.9M
$128.6M
Q4 24
$26.8M
Q3 24
$47.8M
$147.0M
Q2 24
$68.6M
$153.5M
Q1 24
$93.2M
Total Assets
OM
OM
VLN
VLN
Q4 25
$264.5M
Q3 25
$277.3M
$136.7M
Q2 25
$288.8M
$144.8M
Q1 25
$301.2M
$154.6M
Q4 24
$275.8M
Q3 24
$292.9M
$171.9M
Q2 24
$314.5M
$175.8M
Q1 24
$346.2M
Debt / Equity
OM
OM
VLN
VLN
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OM
OM
VLN
VLN
Operating Cash FlowLast quarter
$-9.5M
$-4.7M
Free Cash FlowOCF − Capex
$-9.7M
$-4.9M
FCF MarginFCF / Revenue
-33.7%
-28.5%
Capex IntensityCapex / Revenue
0.8%
1.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M
$-11.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OM
OM
VLN
VLN
Q4 25
$-9.5M
Q3 25
$-6.3M
$-4.7M
Q2 25
$-4.8M
$-211.0K
Q1 25
$-25.7M
$-7.6M
Q4 24
$-16.5M
Q3 24
$-20.6M
$3.0M
Q2 24
$-33.3M
$-225.0K
Q1 24
$-45.9M
Free Cash Flow
OM
OM
VLN
VLN
Q4 25
$-9.7M
Q3 25
$-6.5M
$-4.9M
Q2 25
$-5.1M
$-330.0K
Q1 25
$-25.8M
$-8.0M
Q4 24
$-16.5M
Q3 24
$-21.0M
$2.2M
Q2 24
$-33.5M
$-460.0K
Q1 24
$-46.3M
FCF Margin
OM
OM
VLN
VLN
Q4 25
-33.7%
Q3 25
-22.0%
-28.5%
Q2 25
-16.3%
-1.9%
Q1 25
-86.7%
-47.3%
Q4 24
-56.1%
Q3 24
-73.1%
14.0%
Q2 24
-122.2%
-3.4%
Q1 24
-164.3%
Capex Intensity
OM
OM
VLN
VLN
Q4 25
0.8%
Q3 25
0.5%
1.6%
Q2 25
0.9%
0.7%
Q1 25
0.4%
2.1%
Q4 24
0.1%
Q3 24
1.4%
4.5%
Q2 24
0.4%
1.7%
Q1 24
1.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

VLN
VLN

Segment breakdown not available.

Related Comparisons